EFTA01382300.pdf

DataSet-10 1 page 248 words document
D1
👁 1 💬 0
📄 Extracted Text (248 words)
Amendment No. 3 to Form S-I Table of Contents AB ACQUISITION LLC AND SUBSIDIARIES UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF CONTINUING OPERATIONS 53 WEEKS ENDED FEBRUARY 28, 2015 (in millions except share and per share amounts) Pro Forma Adjustments Pro Forma Pro Forma AB AB related to the Adjustments for Adjustments Acquisition Acquisition Period Safeway IPO-Related for IPO LLC Pro LLC Safeway Inc. Alignment(1) AequisitIon(2) Transaetions(3) Transactions(4) Forma 53 Weeks 53 Weeks 53 Weeks Ended Ended Ended February 28, January 3, February 28, 2015 2015 2015 Net sales and other revenue $ 27,198.6 $ 36,330.2 $ (2,7486) $ (3285.3)2(e) $ $ $ 57.496 9 Cost of sales 19,695.8 26,648.2 (2.060.2) (2,283.3)2(5) 42.013.5 13.0208 Gross profit 7,502.8 9,682 0 (686.4) (1,015.0) 15,483.4 Selling and administrative expenses 8,152.2 9,147.5 (609.3) (1,068.3)2M 15,191 1 (431.0)2(c) Operating (loss) income (649.4) 534.5 (77.1) 484.3 292.3 Interest expense, net 633.2 283.3 (21.3) 4a42(4) 039tra) 848.8 Other expense (income), net 96.0 86.2 (1028) (98.1)2(t) (18.7) (Loss) income from continuing operations before income taxes (1,378.6) 165.0 47.0 539.0 89.8 (537.8) Income tax (benefit) expense (153.4) 61.8 14.2 ($0.2)2(0 (115-0)e<°) 34.74(C) (208.4) Net (loss) income from continuing operations $ (1.225 2) S 103 2 $ 328 $ 589 7 115 0 551 (329 4) Pro forma loss per share. continuing operations Basic and diluted (069)'9 Pro forma weighted average shares outstanding Basic and diluted 475.139.O814(t3 63 http:'/www•.sec.gov Archi‘ edg,aridata/1646972/0001193I25I 5335826'd908395dsla.htm[10,14/20I 5 9:03:02 AM] CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0081602 CONFIDENTIAL SDNY_GM_00227786 EFTA01382300
ℹ️ Document Details
SHA-256
5f3843a08f9b9d439501ebcfd2c3f3120834cd4d71b18c194403d8bd8c420190
Bates Number
EFTA01382300
Dataset
DataSet-10
Type
document
Pages
1

Community Rating

Sign in to rate this document

📋 What Is This?

Loading…
Sign in to add a description

💬 Comments 0

Sign in to join the discussion
Loading comments…
Link copied!